Phase 1 Exercise Clinical Trials
6 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–6 of 6 trials
Recruiting
Phase 1Phase 2
Evaluation of the Walk With Ease Program for Fall Prevention
ExerciseArthritisFrailty+1 more
Iowa State University240 enrolled1 locationNCT05693025
Completed
Phase 1
Individualization of caffeine supplementation in sports based on the analysis of heart rate variability (HRV)
Exercise performance
Poznan University of Medical Sciences300 enrolled1 locationACTRN12622000823774
Completed
Phase 1
Comparative assessment of the absorption of a generic formulation of 5 mg bis [(E)-7-[4-(4-fluorophenyl)- 6-isopropyl-2- [methyl(methylsulfonyl) amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt orally disintegrated tablet (ODT) against the innovator 40 mg bis [(E)-7-[4-(4-fluorophenyl)- 6-isopropyl-2- [methyl(methylsulfonyl) amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt oral tablet conducted under fasting conditions in healthy volunteers.
bis [(E)-7-[4-(4-fluorophenyl)- 6-isopropyl-2- [methyl(methylsulfonyl) amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid] calcium salt is indicated in patients with no hyperchloesterolaemia as an adjunct to diet when the response to diet and exercise is inadequate.
Zenith Technology Corporation Limited16 enrolled1 locationACTRN12621001409864
Completed
Phase 1
The effect of a dietary ketone on immunity, tolerability and performance in well-trained, healthy male cyclists.
Systemic symptoms (e.g. dizziness, nausea)Exercise-Induced immunosuppressionGastrointestinal distress
Auckland University of Technology12 enrolled1 locationACTRN12617001347358
Completed
Phase 1
The effect of a dietary ketone on immunity and tolerability in recreationally active, healthy males at rest.
Systemic symptoms (e.g. dizziness, nausea)Exercise-Induced immunosuppressionGastrointestinal distress
Auckland University of Technology6 enrolled1 locationACTRN12617000731392
Completed
Phase 1
A Phase I, Randomised, Open Label Study of the Safety, Tolerability and Pharmacokinetics of Single Sublingual or Oral Dose of GDN-1 in Adult Healthy Volunteers.
This trial is to assess the tolerability and pharmacokinetics in healthy adult volunteers and does not focus on any particular health condition or problem.
Subsequent studies are planned to evaluate efficacy in promoting improved exercise endurance and recovery, reduced muscle damage and soreness post exercise and for its lipid lowering effects in appropriate populations.
Gordagen Pharmaceuticals Pty Ltd60 enrolled1 locationACTRN12615000560594